SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Fu Howard

(Last) (First) (Middle)
C/O PROCORE TECHNOLOGIES, INC.
6309 CARPINTERIA AVE

(Street)
CARPINTERIA CA 93013

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/08/2023
3. Issuer Name and Ticker or Trading Symbol
PROCORE TECHNOLOGIES, INC. [ PCOR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO & Treasurer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 99,478(1)(2) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents: (i) 25,981 shares of common stock; (ii) 41,000 shares of common stock issuable upon the settlement of the remainder of the restricted stock units ("RSUs") granted on March 16, 2021, one-eighth of which vest quarterly on each February 20, May 20, August 20, and November 20 (each, a "Company Vesting Date"), beginning with the Company Vesting Date of May 20, 2023; (iii) 14,337 shares of common stock issuable upon the settlement of the remainder of the RSUs granted on March 29, 2022, one-twelfth of which vest quarterly on each Company Vesting Date, beginning with the Company Vesting Date of May 20, 2023; (con't below)
2. (Cont'd from footnote 1) and (iv) 18,160 shares of common stock issuable upon the settlement of RSUs granted on March 30, 2023, one-sixteenth of which vest quarterly on each Company Vesting Date, beginning with the Company Vesting Date of May 20, 2023. The vesting of all RSUs described in the preceding sentence is subject to the Reporting Person's continued service through each applicable Company Vesting Date.
Remarks:
/s/ Uyen Nguyen, Attorney-in-fact 05/09/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.